Skip to main content

Table 3 Clinical characteristics associated with AF in patients with hypertension

From: Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study

 

Univariate analysis

Multivariate analysis

OR (95% CI)

P value

OR (95% CI)

P value

HR

1.037 (1.011–1.063)

0.005**

  

BNP levels, pg/ml

1.010 (1.005–1.016)

 < 0.001***

  

Total cholesterol, mmol/l

0.744 (0.525–1.053)

0.095

  

ELABELA levels, ng/ml

0.125 (0.067–0.235)

 < 0.001***

0.081 (0.029–0.224)

 < 0.001***

LAD, mm

1.200 (1.111–1.296)

 < 0.001***

1.273 (1.102–1.472)

0.001**

  1. BNP brain natriuretic peptide, LAD left atrial diameter
  2. *P value less than 0.05; **P value less than 0.01; ***P value less than 0.001